Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tandem Diabetes Care (NQ: TNDM )

31.91 +0.54 (+1.72%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tandem Diabetes Care

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Why Shares of Tandem Diabetes Care Jumped This Week
The company received FDA clearance for a new insulin pump. 
Via The Motley Fool
Why Are Tandem Diabetes Shares Gaining Today?
Tandem Diabetes Care Inc (NASDAQ: TNDM) shares are trading higher after the company received FDA approval for the Tandem Mobi insulin pump for people with diabetes age 6 and up, expanding the... 
Via Benzinga
WD-40, Shutterstock And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Tuesday. Here are some big stocks recording gains in today’s session. Hesai Group (NASDAQ: HSAI) rose 14.4% to $12.34. 
Via Benzinga
Tandem Mobi, World’s Smallest Durable Insulin Delivery System, Receives FDA Clearance
From Tandem Diabetes Care, Inc.
Via Business Wire
The Latest Analyst Ratings for Tandem Diabetes Care
Via Benzinga
8 Analysts Have This to Say About Tandem Diabetes Care
Via Benzinga
Why Tandem Diabetes Care Shares Are Falling Today
Tandem Diabetes Care Inc (NASDAQ: TNDM) shares are down Thursday morning as its Q1 results missed Street expectations. 
Via Benzinga
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million. 
Via Benzinga
Tandem Diabetes Care Earnings Preview
Via Benzinga
Where to Invest $5,000 for the Next 20 Years
These are high-growth opportunities investors should focus on for the long haul. 
Via The Motley Fool
Tandem Diabetes Care to Present at the UBS MedTech, Tools and Genomics Summit 2023
From Tandem Diabetes Care, Inc.
Via Business Wire
Top 5 Health Care Stocks That May Collapse In July
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
2 Health Stocks Down 23% or More This Year That Could Rebound
Don't write them off too soon. 
Via The Motley Fool
Tandem Diabetes Care to Announce Second Quarter 2023 Financial Results on August 3, 2023
From Tandem Diabetes Care, Inc.
Via Business Wire
7 Battered Stocks That Could TRIPLE by 2024
While heavily deflated enterprises are usually that way for a reason, speculators may gamble on these battered stocks to buy. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
  During Thursday, 35 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 69 stocks hit new 52-week lows. 
Via Benzinga
7 Names to Buy as Stock Market Crash Fears Fester
With a downturn representing a non-zero probability, investors should start thinking about these stocks to buy before crash. 
Via InvestorPlace
Got $5,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond.
These stocks have moved in opposite directions lately, but both could deliver solid returns to patient investors. 
Via The Motley Fool
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday's session, 212 companies made new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 221 companies hit new 52-week lows. 
Via Benzinga
Tandem Diabetes Care to Present at the Jefferies Healthcare Conference
From Tandem Diabetes Care, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
  On Friday, 63 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Tuesday, 164 companies hit new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2023
Via Benzinga
Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers 
Via Benzinga
Tandem Diabetes Care Announces First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Pressured As Control-IQ Trials Combined; Raymond James Downgrades TNDM
Tandem Diabetes Care (NASDAQ: TNDM) remained under pressure on Monday, after the company accounted for plans of a combined analysis of three tri 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 24, 2023
Via Benzinga
Tandem Diabetes Care to Present at the BofA Securities 2023 Health Care Conference
From Tandem Diabetes Care, Inc.
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.